Moreover, these factors play a key role in neuroprotection by facilitating the clearance of beta-amyloid and mitigating tau protein hyperphosphorylation, both of which are central to the pathology of Alzheimer's disease (Paillard et al. 2024). Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.